Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP666797.RANqgc0nUCcPFZq6Se9TXna0soJRdE45Bng5AwPe-fM1c130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP666797.RANqgc0nUCcPFZq6Se9TXna0soJRdE45Bng5AwPe-fM1c130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP666797.RANqgc0nUCcPFZq6Se9TXna0soJRdE45Bng5AwPe-fM1c130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP666797.RANqgc0nUCcPFZq6Se9TXna0soJRdE45Bng5AwPe-fM1c130_provenance.
- NP666797.RANqgc0nUCcPFZq6Se9TXna0soJRdE45Bng5AwPe-fM1c130_assertion description "[Fusion gene products such as PML-RARalpha and BCR-ABL generated by leukemia-specific chromosomal translocations have been identified as target molecules for the treatment of leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP666797.RANqgc0nUCcPFZq6Se9TXna0soJRdE45Bng5AwPe-fM1c130_provenance.
- NP666797.RANqgc0nUCcPFZq6Se9TXna0soJRdE45Bng5AwPe-fM1c130_assertion evidence source_evidence_literature NP666797.RANqgc0nUCcPFZq6Se9TXna0soJRdE45Bng5AwPe-fM1c130_provenance.
- NP666797.RANqgc0nUCcPFZq6Se9TXna0soJRdE45Bng5AwPe-fM1c130_assertion SIO_000772 11587362 NP666797.RANqgc0nUCcPFZq6Se9TXna0soJRdE45Bng5AwPe-fM1c130_provenance.
- NP666797.RANqgc0nUCcPFZq6Se9TXna0soJRdE45Bng5AwPe-fM1c130_assertion wasDerivedFrom befree-20140225 NP666797.RANqgc0nUCcPFZq6Se9TXna0soJRdE45Bng5AwPe-fM1c130_provenance.
- NP666797.RANqgc0nUCcPFZq6Se9TXna0soJRdE45Bng5AwPe-fM1c130_assertion wasGeneratedBy ECO_0000203 NP666797.RANqgc0nUCcPFZq6Se9TXna0soJRdE45Bng5AwPe-fM1c130_provenance.
- befree-20140225 importedOn "2014-02-25" NP666797.RANqgc0nUCcPFZq6Se9TXna0soJRdE45Bng5AwPe-fM1c130_provenance.